This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
Progenics Pharmaceuticals Inc
PGNX : NASDAQ : Health Care
$7.24 | %
Today's Range: 6.99 - 7.26
Avg. Daily Volume: 1,131,800
12/26/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
PGNX PROGENICS PHARMACEUTICAL INC 6.99 486.20 139.80 47.92 247.74
PRTA PROTHENA CORP PLC 20.14 551.51 n/m 49.01 4421.03
ONVO ORGANOVO HOLDINGS INC 6.84 550.65 n/m 0.40 -57.87
OSIR OSIRIS THERAPEUTICS INC 14.87 510.34 n/a 48.63 153.75
IMGN IMMUNOGEN INC 5.90 507.02 n/m 55.88 14.83
ZIOP ZIOPHARM ONCOLOGY INC 4.76 488.90 n/m 1.23 54.12
GERN GERON CORP 3.06 481.07 n/m 1.20 -31.32
HPTX HYPERION THERAPEUTICS INC 21.91 454.04 n/m 101.41 330.10
SPPI SPECTRUM PHARMACEUTICALS INC 6.90 453.74 n/m 176.49 -0.20
XOMA XOMA CORP 3.68 424.93 n/m 27.05 -10.75
IMMU IMMUNOMEDICS INC 4.41 410.72 n/m 4.62 -50.95
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

PGNX Ind Avg S&P 500
139.80 69.32 20.19

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs